SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"
Status:
Completed
Trial end date:
2021-10-06
Target enrollment:
Participant gender:
Summary
Primary Objective:
To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to
severe atopic dermatitis (AD)
Secondary Objectives:
To evaluate the effect of dupilumab on objective and subjective quantitative sleep
parameters, AD related outcomes, and daytime consequences of sleep deprivation
To continue to assess the safety and tolerability throughout the study